FORM 8-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

December 23, 2025

Period of Report

December 18, 2025

Accession Number

0001437749-25-038602

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →